stoxline Quote Chart Rank Option Currency Glossary
Rockwell Medical, Inc. (RMTI)
1.84  -0.055 (-2.9%)    06-13 16:00
Open: 1.89
High: 1.915
Volume: 103,389
Pre. Close: 1.895
Low: 1.82
Market Cap: 56(M)
Technical analysis
2024-06-13 4:46:00 PM
Short term     
Mid term     
Targets 6-month :  2.31 1-year :  2.7
Resists First :  1.98 Second :  2.31
Pivot price 1.82
Supports First :  1.74 Second :  1.6
MAs MA(5) :  1.87 MA(20) :  1.81
MA(100) :  1.55 MA(250) :  2.12
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  67.1 D(3) :  70.1
RSI RSI(14): 58.8
52-week High :  6.23 Low :  1.15
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ RMTI ] has closed below upper band by 43.1%. Bollinger Bands are 21.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.92 - 1.93 1.93 - 1.94
Low: 1.8 - 1.81 1.81 - 1.82
Close: 1.82 - 1.84 1.84 - 1.86
Company Description

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Headline News

Fri, 14 Jun 2024
Rockwell Medical (NASDAQ:RMTI) Shares Pass Above 200 Day Moving Average of $1.60 - Defense World

Thu, 06 Jun 2024
Armistice Capital LLC Sells 965,000 Shares of Rockwell Medical, Inc. (NASDAQ:RMTI) - MarketBeat

Thu, 30 May 2024
Rockwell Medical Promotes Tim Chole to Chief Commercial Officer - Business Wire

Tue, 14 May 2024
Rockwell Medical Announces First Quarter 2024 Results, Raises 2024 Guidance - Business Wire

Tue, 14 May 2024
Earnings call: Rockwell Medical reports growth and optimistic 2024 outlook By -

Tue, 14 May 2024
Rockwell Medical, Inc. (RMTI) Q1 2024 Earnings Call Transcript - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Drug Manufacturers - Specialty & Generic
Shares Out 30 (M)
Shares Float 25 (M)
Held by Insiders 8.3 (%)
Held by Institutions 18 (%)
Shares Short 633 (K)
Shares Short P.Month 638 (K)
Stock Financials
EPS -0.34
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.69
Profit Margin -9.8 %
Operating Margin -5.9 %
Return on Assets (ttm) -9 %
Return on Equity (ttm) -50.8 %
Qtrly Rev. Growth 15.3 %
Gross Profit (p.s.) 0
Sales Per Share 2.85
EBITDA (p.s.) -0.16
Qtrly Earnings Growth 0 %
Operating Cash Flow -8 (M)
Levered Free Cash Flow -4 (M)
Stock Valuations
PE Ratio -5.58
PEG Ratio -0.4
Price to Book value 2.62
Price to Sales 0.64
Price to Cash Flow -7.05
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android